Search Results
Jun 02, 2026, 00:54 ET High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease
the patient achieved rapid and efficient hematopoietic reconstitution, with neutrophil engraftment observed on Day 13 and platelet counts exceeding 50×10^9/L on Day 21 post-treatment. Within one month after treatment, fetal hemoglobin (HbF) levels increased significantly and continuously, while sickle hemoglobin
More news about: CorrectSequence Therapeutics
Jun 02, 2026, 00:50 ET High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease
the patient achieved rapid and efficient hematopoietic reconstitution, with neutrophil engraftment observed on Day 13 and platelet counts exceeding 50×10^9/L on Day 21 post-treatment. Within one month after treatment, fetal hemoglobin (HbF) levels increased significantly and continuously, while sickle hemoglobin
More news about: CorrectSequence Therapeutics
Jun 01, 2026, 21:30 ET MSI presenteert vloeistofgekoelde AI-infrastructuur, NVIDIA MGX, NVIDIA DGX Station en DC-MHS-platformen op COMPUTEX 2026
21" 44OU ORv3-vloeistofgekoelde rekarchitectuur ondersteunt implementaties tot 100 kW met een geïntegreerde Liquid-to-Liquid Coolant Distribution Unit (L2L CDU, vloeistof-tot-vloeistof koelmiddeldistributieeenheid). Geconfigureerd met 28 x 1OU2N Open Compute multi-node-systemen, zorgt het bredere 21" ORv3-ontwerp
More news about: MSI
Jun 01, 2026, 21:30 ET MSI Showcases Liquid-Cooled AI Infrastructure, NVIDIA MGX, NVIDIA DGX Station and DC-MHS Platforms at COMPUTEX 2026
environments.The 21" 44OU ORv3 Liquid-Cooled Rack Architecture supports up to 100kW deployments with an integrated Liquid-to-Liquid Coolant Distribution Unit (L2L CDU). Configured with 28x 1OU2N Open Compute multi-node systems, the wider 21" ORv3 design enables higher compute density, efficient liquid cooling,
More news about: MSI
Jun 01, 2026, 21:30 ET MSI präsentiert auf der COMPUTEX 2026 flüssigkeitsgekühlte KI-Infrastruktur sowie die Plattformen NVIDIA MGX, NVIDIA DGX Station und DC-MHS
unterstützt Installationen mit einer Leistung von bis zu 100 kW und verfügt über eine integrierte Flüssigkeit-zu-Flüssigkeit-Kühlmittelverteilungseinheit (L2L CDU). Das breitere 21-Zoll-ORv3-Design, das mit 28 Open-Compute-Multi-Node-Systemen vom Typ 1OU2N konfiguriert ist, ermöglicht eine höhere Rechendichte,
More news about: MSI
Jun 01, 2026, 21:30 ET MSI Showcases Liquid-Cooled AI Infrastructure, NVIDIA MGX, NVIDIA DGX Station and DC-MHS Platforms at COMPUTEX 2026
environments.The 21" 44OU ORv3 Liquid-Cooled Rack Architecture supports up to 100kW deployments with an integrated Liquid-to-Liquid Coolant Distribution Unit (L2L CDU). Configured with 28x 1OU2N Open Compute multi-node systems, the wider 21" ORv3 design enables higher compute density, efficient liquid cooling,
More news about: MSI
Jun 01, 2026, 21:30 ET MSI présente l'infrastructure IA à refroidissement liquide, les plateformes NVIDIA MGX, NVIDIA DGX Station et DC-MHS au COMPUTEX 2026.
ORv3 21" à refroidissement par liquide prend en charge des déploiements jusqu'à 100 kW grâce à une unité de refroidissement liquide/liquide intégrée (L2L CDU). Configuré avec 28 systèmes multi-nœuds 1OU2N Open Compute, le design ORv3 21" plus large permet une plus grande densité de calcul, un refroidissement
More news about: MSI
Jun 01, 2026, 21:00 ET Peak Performance: Toyota Introduces the 2026 GRMN Corolla
EngineG16E-GTS 1.6L, 3-cylinder port injected turbo, 12-VALVE DOHC
More news about: Toyota Motor North America
Jun 01, 2026, 19:37 ET MemryX Appoints Ross Jatou as CEO and Joe Faris as VP of Sales and Marketing to Accelerate AI Infrastructure Expansion
moment for a leadership transition. Ross brings extensive executive experience in the global semiconductor space, spanning engineering leadership and P&L roles. MemryX has an exceptional engineering team and a strong fundamental architecture, and I'm confident Ross is well positioned to lead the company
More news about: MemryX
Jun 01, 2026, 18:58 ET CoolIT Systems Demonstrates 15kW Coldplate, Extending Single-Phase DLC Roadmap Far Beyond 2030
2025.The 15kW coldplate uses CoolIT's Split-Flow™ microchannel architecture and was validated with a standard water-glycol coolant at 1.2 L/min/kW, with system-level thermal performance suitable for 45°C warm-water cooling environments."AI accelerator innovation depends on cooling architectures
More news about: CoolIT Systems Inc
Jun 01, 2026, 17:08 ET MemryX Appoints Ross Jatou as CEO and Joe Faris as VP of Sales and Marketing to Accelerate AI Infrastructure Expansion
moment for a leadership transition. Ross brings extensive executive experience in the global semiconductor space, spanning engineering leadership and P&L roles. MemryX has an exceptional engineering team and a strong fundamental architecture, and I'm confident Ross is well positioned to lead the company
More news about: MemryX
Jun 01, 2026, 16:05 ET Cirius Therapeutics Announces Presentation on CIR-0602K as Novel Diabetes Treatment at the American Diabetes Association's 2026 Scientific Sessions
Options to Manage Diabetes [Board No. 1794]Authors: M. Abu-Farha, I. Al Khairi, J.A. Abubaker, R.A. DeFronzo, M. Abdul-Ghani, L. Norton, J.R. Colca, F. Al-Mulla, K.S. McCommisDate & Time: Sunday, June 7, at 12:30 AM CT (poster will be up throughout
More news about: Cirius Therapeutics
Jun 01, 2026, 16:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
https://www.clinicaltrials.gov/study/NCT05740566.Rudin CM, Mountzios GS, Sun L, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small-cell lung cancer: primary analysis of Ph3 DeLLphi-304. Oral presentation at: ASCO Annual Meeting;
More news about: Amgen
Jun 01, 2026, 13:45 ET 20 Willig, Williams & Davidson Attorneys Named 2026 PA Super Lawyers & Rising Stars
Amy L. Rosenberger
More news about: Willig, Williams & Davidson
Jun 01, 2026, 13:23 ET Bambu Lab lanza A2L: Espacio creativo. Extra grande
disponibilidadA2L:EE.UU.: 469 USD (excl. impuestos / incl. envío)UE: 379 EUR (incl. impuestos / excl. envío)A2L Combo (AMS Lite):EE.UU.: 569 USD (excl. impuestos / incl. envío)UE: 489 EUR (incl. impuestos / excl. envío)La A2L/A2L Combo está disponible
More news about: Bambu Lab
Jun 01, 2026, 12:00 ET Invesco Closed-End Funds Declare Dividends
are bought on the secondary market and may trade at a discount or premium to NAV. Regular brokerage commissions apply.NOT A DEPOSIT l NOT FDIC INSURED l NOT GUARANTEED BY THE BANK | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCYContact: Closed-End Funds 800-341-2929
More news about: Invesco Ltd.
Jun 01, 2026, 11:56 ET FOX WEATHER EXPANDS DISTRIBUTION TO SIRIUSXM STARTING JUNE 3 AS HURRICANE SEASON BEGINS
hurricane season on June 1, will be offered to listeners across North America via the SiriusXM app (ch. 799) and in vehicles equipped with SiriusXM with 360L. Access to the SiriusXM app is included with most SiriusXM subscriptions. In addition, during major weather events, FOX Weather will also be available
More news about: Fox News Network, LLC
Jun 01, 2026, 11:11 ET UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members
Suppurativa on Major Life-Changing Decisions: A Cross-Sectional Study. Indian J Dermatol. 2025;70(5):283-286.Sabat R, Jemec GBE, Matusiak L, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl
More news about: UCB
Jun 01, 2026, 11:00 ET IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO
analysis of their registrational Phase 2/3 OptimUM-02 trial of darovasertib in combination with crizotinib (darovasertib combination) in first line (1L) HLA*A2:01 negative metastatic uveal melanoma (mUM) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicago,
More news about: IDEAYA Biosciences, Inc.
Jun 01, 2026, 10:04 ET Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
analytical and process development, and GMP clinical manufacturing services of drug substances and drug products of the combination NOVAKnee-T and NOVAKnee-L implants for human use in a Phase 1 clinical trial in the US, anticipated to begin in 2028.NOVAKnee is designed to replace traditional metal and
More news about: Made Scientific, Inc.
Jun 01, 2026, 10:00 ET Bambu Lab Launches A2L: Creative Playground. Extra Large.
1, 2026 /PRNewswire/ -- Bambu Lab today announced the launch of the A2L, a large-format 3D printer designed for ambitious creative projects that previously required splitting large models into multiple pieces. The A2L represents a new category within the Bambu ecosystem – the
More news about: Bambu Lab
Jun 01, 2026, 10:00 ET Bambu Lab Launches A2L: Creative Playground. Extra Large.
AvailabilityA2L: US: 469 USD (excl. tax / incl. shipping)EU: 379 EUR (incl. tax / excl. shipping)A2L Combo (AMS Lite): US: 569 USD (excl. tax / incl. shipping)EU: 489 EUR (incl. tax / excl. shipping)The A2L/A2L Combo is available globally
More news about: Bambu Lab
Jun 01, 2026, 08:54 ET dxFeed Grenadier Recognized as Best AI-based Solution at Waterstechnology Asia Awards 2026
to build: a production-grade AI tool that integrates directly into the data infrastructure institutional clients already utilize. Grenadier turns raw L2 data into actionable market intelligence — at the speed markets demand," said
More news about: dxFeed
Jun 01, 2026, 08:31 ET The Evolving EGFR NSCLC Market: 8 Emerging Late-stage Therapies to Watch | DelveInsight
trials. Developed using the company's proprietary Tetrabody platform, the therapy is designed to simultaneously inhibit PD-1 interactions with PD-L1 and PD-L2 while also preventing VEGF from binding to its receptors.The combination of PD-1 inhibition and VEGF blockade has already demonstrated strong
More news about: DelveInsight Business Research, LLP
Jun 01, 2026, 08:25 ET National Soul Food Month® Celebrates 25 Years of Culture, Cuisine, and Community in June 2026
connect people through food, culture and storytelling."We are incredibly proud to celebrate 25 years of National Soul Food Month," said Charla L. Draper, founder of this historic recognition. "Our goal in celebrating throughout the month is to promote it, educate the public about the food and food-related
More news about: It's Food Biz! for National Soul Food Month